The alterations in neurotransmitters and their metabolites in discrete brain regions in the rats after inhalation of disinfectant, glutaraldehyde or ortho-phthalaldehyde for 4 weeks

Industrial Health

Volumn 49, Issue 3, 2011, Pages 328-337

  Katagiri, Hiroshi ^a   Yamamoto, Tetsushi ^a   Uchimura, Ayako ^a   Tsunoda, Masashi ^b   Aizawa, Yoshiharu ^b   Yamauchi, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine; Gluraraldehyde; Neurotoxicity; Ortho phthalaldehyde

Indexed keywords

DISINFECTANT AGENT; GLUTARALDEHYDE; PHTHALALDEHYDE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN; DISEASE MODEL; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; METABOLISM; RAT; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DISINFECTANTS; ENVIRONMENTAL EXPOSURE; FEMALE; GLUTARAL; INHALATION EXPOSURE; LIVER; O-PHTHALALDEHYDE; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 79959290391     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.MS1156     Document Type: Article

References (26)

1. Beauchamp RO Jr, St Clair MB, Fennell TR, Clarke DO, Morgan KT, Kari FW (1992) A critical review of the toxicology of glutaraldehyde. Crit Rev Toxicol 22, 143-74.
2. Walsh SE, Mailard JY, Russell AD (1999) Orthophthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 86, 1039-46.
3. American Conference of Governmental Industrial Hygienists (1996) Glutaraldehyde. Documentation of the use and handling of glutaraldehyde-based products in health care facilities (ANSI/AAMI ST 58), ACGIH, Cincinnati.
4. Jachuck SJ, Bound CL, Steel J, Blain PG (1989) Occupational hazard in hospital staff exposed to 2 per cent glutaraldehyde in an endoscopy unit. J Soc Occup Med 39, 69-71.
5. Katagiri H, Suzuki T, Aizawa Y, Kadowaki T (2006) Indoor glutaraldehyde levels in the endoscope disinfecting room and subjective symptoms among workers. Ind Health 44, 225-9.
6. Chan-Yeung M, McMurren T, Catonio-Begley F, Lam S (1993) Occupational asthma in a technologist exposed to glutaraldehyde. J Allergy Clin Immunol 91, 974-8.
7. Ong TH, Tan KL, Lee HS, Eng P (2004) A case report of occupational asthma due to gluteraldehyde exposure. Ann Acad Med Singapore 33, 275-8.
8. Sokol WN (2004) Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (orthophthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J Allergy Clin Immunol 114, 392-7.
9. Rideout K, Teschke K, Dimich-Ward H, Kennedy SM (2005) Considering risks to healthcare workers from glutaraldehyde alternatives in high-level disinfection. J Hosp Infect 59, 4-11.
10. Rozman KK, Klassen CD (2001) Disposition of toxicants. Absorption, distribution and excretion of toxicants. In: Casarett and Doull's Toxicology. The Basic Science of Poisons. 6th Ed., Klassen CD (Ed.), 107-32. McGraw Hill, New York.
11. Corsini GU, Zuddas A, Bonuccelli U, Schinelli S, Kopin IJ (1987) 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) neurotoxicity in mice enhanced by ethanol or acetaldehyde. Life Sci 40, 827-32.
12. Honma T, Miyagawa M, Sato M (1987) Methyl bromide alters catecholamine and metabolite concentrations in rat brain. Neurotoxicol Teratol 9, 369-75.
13. O'Kusky JR, Boyes BE, McGeer EG (1988) Methylmercury-induced movement and postural disorders in developing rat: regional analysis of brain catecolamines and indoleamines. Brain Res 439, 138-46.
14. Tsunoda M, Konno N, Nakano K, Liu Y (2004) Altered metabolism of dopamine in the midbrain of mice treated with tributyltin chloride via subacute oral exposure. Environ Sci 11, 209-19.
15. Filipov NM, Thompson FN, Tsunoda M, Sharma RP (1999) Region-specific decrease of dopamine and its metabolites in brains of mice given ergotamine. J Toxicol Environ Health 56, 47-58.
16. Sharma RP, Bhandari N, Tsunoda M, Riley RT, Voss KA, Meredith FI (2000) Fumonisin toxicity in a trangenic mouse model lacking the mdr1a/1b P-glycoprotein genes. Environ Toxicol Pharmacol 8, 173-82.
17. Szostak C, Jakubovic A, Phillips AG, Fibiger C (1986) Bilateral augmentation of dopaminergic and serotonergic activity in the striatum and nucleus accumbens induced by conditioned cycling. J Neurosci 6, 2037-44.
18. Tsunoda M, Aizawa Y, Konno N, Kimura K, Sugita-Konishi Y (2006) Subacute administration of tributyltin chloride modulates neurotransmitters and their metabolites in discrete brain regions of maternal mice and their F1 offspring. Toxicol Ind Health 22, 15-25.
19. Akamatsu T, Yano I, Okimura Y, Yokoyama T, Nakamura N, Kiyosawa K, Katsuyama T (2003) Infection control of gastrointestinal endoscopy: present status and problems in Japan. Shoukaki Naishikyo 15, 11-6 (in Japanese).
20. Takigawa T, Endo Y (2006) Effects of glutaraldehyde exposure on human health. J Occup Health 48, 75-87.
21. Fujita H, Sawada Y, Ogawa M, Endo Y (2007) Health hazards from exposure to ortho-phthalaldehyde, a dis infectant for endoscopes, and preventative measures for health care workers. Sangyo Eiseigaku Zasshi 49, 1-8 (in Japanese).
22. van Birgelen AP, Chou BJ, Renne RA, Grumbein SL, Roycroft JH, Hailey JR, Bucher JR (2000) Effects of glutaraldehyde in a 2-year inhalation study in rats and mice. Toxicol Sci 55, 195-205.
23. Zissu D, Bonnet P, Binet S (1998) Histopathological study in B6C3F1 mice chronically exposed by inhalation to glutaraldehyde. Toxicol Lett 95, 131-9.
24. Cooper JR, Bloom FE, Roth RH (2003) Dopamine. In: The biochemical basis of neuropharmacology, 8th Ed., Cooper JR, Bloom FE, Roth RH (Eds.), 225-70 Oxford University Press, New York.
25. Esteban A, Gimenez-Roldan S (1975) Blink reflex in Huntington's chorea and Parkinson's disease. Acta Neurol Scand 52, 145-57.
26. Leibowitz SF (1987) Hypothalamic neurotransmitters in relation to normal and disturbed eating patterns. Ann N Y Acad Sci 499, 137-43.